Amyndas Pharmaceuticals
Pre-clinicalDevelops complement therapeutics for infectious, inflammatory, and autoimmune diseases.
Founded
2011
Focus
RNA & Gene Therapy
About
Develops complement therapeutics for infectious, inflammatory, and autoimmune diseases.
Funding History
2Total raised: $85M
Series B$60MPfizerJun 15, 2020
Series A$25MUndisclosedJun 15, 2017
Company Info
TypePrivate
Founded2011
LocationAthens, Europe - Other
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
3D BioLabs
Pre-clinical · Sarajevo
Bilim Pharmaceuticals
Pre-clinical · Istanbul
3Z Pharmaceuticals
Pre-clinical · Reykjavik
ADAX
Pre-clinical · Ljubljana
Exolitus
Pre-clinical · Vienna
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile